Display options
Cite
Suarez-Carmona M, Chaorentong P, Kather JN, et al. CCR5 status and metastatic progression in colorectal cancer. Oncoimmunology. 2019;8(9):e1626193doi: 10.1080/2162402X.2019.1626193.
Suarez-Carmona, M., Chaorentong, P., Kather, J. N., Rothenheber, R., Ahmed, A., Berthel, A., Heinzelmann, A., Moraleda, R., Valous, N. A., Kosaloglu, Z., Eurich, R., Wolf, J., Grauling-Halama, S., Hundemer, M., Lasitschka, F., Klupp, F., Kahlert, C., Ulrich, A., Schneider, M., Falk, C., Jäger, D., Zoernig, I., & Halama, N. (2019). CCR5 status and metastatic progression in colorectal cancer. Oncoimmunology, 8(9), e1626193. https://doi.org/10.1080/2162402X.2019.1626193
Suarez-Carmona, Meggy, et al. "CCR5 status and metastatic progression in colorectal cancer." Oncoimmunology vol. 8,9 (2019): e1626193. doi: https://doi.org/10.1080/2162402X.2019.1626193
Suarez-Carmona M, Chaorentong P, Kather JN, Rothenheber R, Ahmed A, Berthel A, Heinzelmann A, Moraleda R, Valous NA, Kosaloglu Z, Eurich R, Wolf J, Grauling-Halama S, Hundemer M, Lasitschka F, Klupp F, Kahlert C, Ulrich A, Schneider M, Falk C, Jäger D, Zoernig I, Halama N. CCR5 status and metastatic progression in colorectal cancer. Oncoimmunology. 2019 Jul 13;8(9):e1626193. doi: 10.1080/2162402X.2019.1626193. eCollection 2019. PMID: 31428524; PMCID: PMC6685512.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2019 Jul 13;8(9):e1626193. doi: 10.1080/2162402X.2019.1626193. eCollection 2019.

CCR5 status and metastatic progression in colorectal cancer.

Oncoimmunology

Meggy Suarez-Carmona, Pornpimol Chaorentong, Jakob Nikolas Kather, Rebecca Rothenheber, Azaz Ahmed, Anna Berthel, Anita Heinzelmann, Rodrigo Moraleda, Nektarios A Valous, Zeynep Kosaloglu, Rosa Eurich, Jana Wolf, Silke Grauling-Halama, Michael Hundemer, Felix Lasitschka, Fee Klupp, Christoph Kahlert, Alexis Ulrich, Martin Schneider, Christine Falk, Dirk Jäger, Inka Zoernig, Niels Halama

Affiliations

  1. Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  2. Medical oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  3. Helmholtz Center for Translational Oncology (HITRON), Mainz, Germany.
  4. Clinical Cooperation Unit Applied Tumor Immunity, National Center for Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.
  5. Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  6. Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany.
  7. Institute for Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  8. Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  9. Department of Surgery, University Hospital Dresden, Dresden, Germany.
  10. Institute of Transplant Immunology, Integrated Research and Treatment Center Transplantation, Hannover Medical School Hannover, Hanover, Germany.
  11. Department of Internal Medicine VI, University Hospital Heidelberg, Heidelberg, Germany.
  12. Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany.

PMID: 31428524 PMCID: PMC6685512 DOI: 10.1080/2162402X.2019.1626193

Abstract

Multiple reports have highlighted the importance of the local immunological cellular composition (

Keywords: CCL5; CCR5; T cells; colorectal cancer; disease free survival; immune checkpoint; immunotherapy; macrophages; microenvironment

References

  1. Immunol Rev. 2000 Oct;177:99-111 - PubMed
  2. J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):472-81 - PubMed
  3. J Am Soc Nephrol. 2002 Mar;13(3):754-8 - PubMed
  4. Cell Signal. 2004 Nov;16(11):1201-10 - PubMed
  5. Int J Cancer. 2005 Oct 10;116(6):949-56 - PubMed
  6. Cancer Res. 2005 Sep 15;65(18):8072-8 - PubMed
  7. J Exp Med. 2005 Oct 17;202(8):1075-85 - PubMed
  8. Science. 2006 Sep 29;313(5795):1960-4 - PubMed
  9. J Clin Invest. 2006 Oct;116(10):2777-90 - PubMed
  10. Nature. 2007 Oct 4;449(7162):557-63 - PubMed
  11. J Clin Invest. 2008 Jun;118(6):1991-2001 - PubMed
  12. Curr Opin HIV AIDS. 2009 Mar;4(2):96-103 - PubMed
  13. AIDS Read. 2009 Jun-Jul;19(6):218-22, 224 - PubMed
  14. Eur J Immunol. 2010 Jan;40(1):22-35 - PubMed
  15. Cytokine Growth Factor Rev. 2010 Feb;21(1):27-39 - PubMed
  16. Int J Colorectal Dis. 2010 Apr;25(4):417-24 - PubMed
  17. Curr Top Microbiol Immunol. 2011;344:1-24 - PubMed
  18. Semin Immunopathol. 2011 Jul;33(4):335-40 - PubMed
  19. Cancer Res. 2011 Sep 1;71(17):5670-7 - PubMed
  20. PLoS One. 2011;6(12):e28842 - PubMed
  21. Brief Bioinform. 2013 Mar;14(2):178-92 - PubMed
  22. Cancer Res. 2012 Aug 1;72(15):3839-50 - PubMed
  23. N Engl J Med. 2012 Jul 12;367(2):135-45 - PubMed
  24. Science. 2013 Jan 18;339(6117):286-91 - PubMed
  25. Eur J Cancer. 2013 Jul;49(11):2476-85 - PubMed
  26. Nat Genet. 2013 Aug;45(8):927-32 - PubMed
  27. Transl Oncol. 2013 Dec 01;6(6):784-93 - PubMed
  28. Tumour Biol. 2014 Jun;35(6):5895-904 - PubMed
  29. Cancer Res. 2014 Dec 1;74(23):7103-14 - PubMed
  30. AIDS. 2015 May 15;29(8):867-76 - PubMed
  31. Oncotarget. 2015 Mar 20;6(8):5846-59 - PubMed
  32. Oncoimmunology. 2015 Jun 5;4(7):e1058597 - PubMed
  33. Eur J Cancer. 2015 Nov;51(17):2708-17 - PubMed
  34. N Engl J Med. 2015 Nov 12;373(20):1979 - PubMed
  35. Adv Immunol. 2016;130:95-190 - PubMed
  36. Gut. 2017 Apr;66(4):633-643 - PubMed
  37. Oncotarget. 2016 Apr 26;7(17):24495-509 - PubMed
  38. Cancer Cell. 2016 Apr 11;29(4):587-601 - PubMed
  39. Virology. 2016 Jul;494:198-214 - PubMed
  40. Open Biol. 2016 Jun;6(6): - PubMed
  41. Oncotarget. 2016 Jul 26;7(30):48335-48345 - PubMed
  42. Oncoimmunology. 2016 Mar 10;5(6):e1150398 - PubMed
  43. Oncol Rep. 2016 Dec;36(6):3522-3528 - PubMed
  44. Expert Opin Investig Drugs. 2016 Dec;25(12):1377-1392 - PubMed
  45. Sci Rep. 2017 Dec 4;7(1):16878 - PubMed
  46. Sci Rep. 2018 Jan 22;8(1):1323 - PubMed
  47. Lancet. 2018 May 26;391(10135):2128-2139 - PubMed
  48. Int J Mol Sci. 2018 May 16;19(5):null - PubMed
  49. Elife. 2018 Sep 04;7: - PubMed
  50. Haematologica. 2019 Mar;104(3):564-575 - PubMed
  51. Clin Cancer Res. 2019 Jul 1;25(13):3873-3886 - PubMed
  52. Cell Death Dis. 2019 Mar 19;10(4):264 - PubMed
  53. Br J Cancer. 2019 Apr;120(9):871-882 - PubMed
  54. Nature. 1996 Jun 20;381(6584):661-6 - PubMed
  55. Cell. 1996 Jun 28;85(7):1135-48 - PubMed
  56. Nature. 1996 Aug 22;382(6593):722-5 - PubMed
  57. Lancet. 1998 Jan 3;351(9095):14-8 - PubMed

Publication Types